WO2002024752A3 - Anticorps monoclonaux diriges contre des structures lipidiques differentes de la bicouche de membranes cellulaires afin de definir des etats physiologiques dans differents types cellulaires et afin de detecter des anticorps diriges contre des particules lipidiques presents chez des individus et/ou des animaux - Google Patents
Anticorps monoclonaux diriges contre des structures lipidiques differentes de la bicouche de membranes cellulaires afin de definir des etats physiologiques dans differents types cellulaires et afin de detecter des anticorps diriges contre des particules lipidiques presents chez des individus et/ou des animaux Download PDFInfo
- Publication number
- WO2002024752A3 WO2002024752A3 PCT/MX2001/000069 MX0100069W WO0224752A3 WO 2002024752 A3 WO2002024752 A3 WO 2002024752A3 MX 0100069 W MX0100069 W MX 0100069W WO 0224752 A3 WO0224752 A3 WO 0224752A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- different
- monoclonal antibodies
- double layer
- antibodies
- certain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001288136A AU2001288136A1 (en) | 2000-09-01 | 2001-08-31 | Monoclonal antibodies against lipid structures different from the double layer of cell membranes for defining physiological states in different cell types and detecting anti lipid particle antibodies in human beings and/or animals suffering from certain antiphospholipid antibody-related diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA/A/2000/008567A MXPA00008567A (en) | 2000-09-01 | Monoclonal antibodies against lipid structures different from the two-layer of cellular membranes to define phsycological states in different cellular types and for the detection of antiparticles antibodies | |
MX008567 | 2000-09-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002024752A2 WO2002024752A2 (fr) | 2002-03-28 |
WO2002024752A3 true WO2002024752A3 (fr) | 2002-07-18 |
Family
ID=34101929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/MX2001/000069 WO2002024752A2 (fr) | 2000-09-01 | 2001-08-31 | Anticorps monoclonaux diriges contre des structures lipidiques differentes de la bicouche de membranes cellulaires afin de definir des etats physiologiques dans differents types cellulaires et afin de detecter des anticorps diriges contre des particules lipidiques presents chez des individus et/ou des animaux |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001288136A1 (fr) |
WO (1) | WO2002024752A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104155451B (zh) * | 2014-08-20 | 2016-01-06 | 厦门大学附属中山医院 | 梅毒螺旋体IgM抗体生物素亲和素酶联免疫检测试剂盒及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983002672A1 (fr) * | 1982-02-02 | 1983-08-04 | Hana Biolog Inc | Analyse immunologique permettant de determiner la presence d'un phospholipide dans un fluide biologique |
US4666831A (en) * | 1985-02-19 | 1987-05-19 | The Liposome Company, Inc. | Lipid-dependent diagnostic assays |
US4698299A (en) * | 1985-02-19 | 1987-10-06 | The Liposome Company, Inc. | Lipid-dependent diagnostic assays |
WO1997040387A1 (fr) * | 1996-04-19 | 1997-10-30 | Pasteur Sanofi Diagnostics, S.A. | Dosages immunologiques de detection d'anticorps antiphospholipides |
WO1997039736A1 (fr) * | 1996-04-19 | 1997-10-30 | Pasteur Sanofi Diagnostics, S.A. | Reactifs a base de liposomes pour dosages immunologiques |
WO1999002992A1 (fr) * | 1997-07-11 | 1999-01-21 | The Mount Sinai School Of Medicine Of The City University Of New York | Tests pour le diagnostic de thrombophilie |
-
2001
- 2001-08-31 WO PCT/MX2001/000069 patent/WO2002024752A2/fr active Application Filing
- 2001-08-31 AU AU2001288136A patent/AU2001288136A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983002672A1 (fr) * | 1982-02-02 | 1983-08-04 | Hana Biolog Inc | Analyse immunologique permettant de determiner la presence d'un phospholipide dans un fluide biologique |
US4666831A (en) * | 1985-02-19 | 1987-05-19 | The Liposome Company, Inc. | Lipid-dependent diagnostic assays |
US4698299A (en) * | 1985-02-19 | 1987-10-06 | The Liposome Company, Inc. | Lipid-dependent diagnostic assays |
WO1997040387A1 (fr) * | 1996-04-19 | 1997-10-30 | Pasteur Sanofi Diagnostics, S.A. | Dosages immunologiques de detection d'anticorps antiphospholipides |
WO1997039736A1 (fr) * | 1996-04-19 | 1997-10-30 | Pasteur Sanofi Diagnostics, S.A. | Reactifs a base de liposomes pour dosages immunologiques |
WO1999002992A1 (fr) * | 1997-07-11 | 1999-01-21 | The Mount Sinai School Of Medicine Of The City University Of New York | Tests pour le diagnostic de thrombophilie |
Also Published As
Publication number | Publication date |
---|---|
WO2002024752A2 (fr) | 2002-03-28 |
AU2001288136A1 (en) | 2002-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6335796B2 (ja) | Cdim結合タンパク質及びその使用 | |
Zuo et al. | IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid | |
WO1998057994A3 (fr) | Anticorps opsoniques, monoclonaux protecteurs, et chimeres specifiques a l'acide lipoteichoique des bacteries gram positif | |
AU2016258628A1 (en) | Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof | |
US10858446B2 (en) | Anti-PCSK9 antibodies and uses thereof | |
CA2380783A1 (fr) | Anticorps monoclonaux humains de l'antigene d'enveloppe prostatique specifique | |
CN107955072A (zh) | Pd-1抗体 | |
CN107735093A (zh) | Cd123抗体和其结合物 | |
EA038470B1 (ru) | СВЯЗЫВАЮЩЕЕСЯ С FcRn АНТИТЕЛО ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ ЗАБОЛЕВАНИЙ | |
WO2004045512A3 (fr) | Anticorps monoclonaux humains contre cd25 | |
WO2004043989A3 (fr) | Anticorps monoclonaux humains diriges contre l'heparanase | |
JP2003534781A5 (fr) | ||
WO2003040169A3 (fr) | Anticorps monoclonaux humains diriges contre les cellules dendritiques | |
Getman et al. | Pharmacokinetic effects of 4C9, an anti-FcRn antibody, in rats: implications for the use of FcRn inhibitors for the treatment of humoral autoimmune and alloimmune conditions | |
CA2225852A1 (fr) | Anticorps anti-ligand fas et methode de dosage le faisant intervenir | |
JP2016513682A (ja) | 抗血漿カリクレイン抗体 | |
EP0585224A1 (fr) | ANTICORPS MONOCLONAUX QUI SE LIENT A L'IgE SECRETEE ET LIEE AUX MEMBRANES MAIS QUI NE SE LIENT PAS A L'IgE SE TROUVANT SUR LES LEUCOCYTES BASOPHILES | |
PT2432804E (pt) | Anticorpos ou seus fragmentos direcionados contra um epítopo de staphylococcus aureus de isaa ou isab | |
AT503297B1 (de) | Allergen-spezifische antikörper | |
WO2002024752A3 (fr) | Anticorps monoclonaux diriges contre des structures lipidiques differentes de la bicouche de membranes cellulaires afin de definir des etats physiologiques dans differents types cellulaires et afin de detecter des anticorps diriges contre des particules lipidiques presents chez des individus et/ou des animaux | |
US9718891B2 (en) | Antibodies specific to a novel epitope on CεMX of human membrane-bound IgE and uses thereof in treating IgE-mediated diseases | |
US20040081649A1 (en) | Treating Atopic dermatitis with IgE antagonists | |
Lamoureux et al. | Autoantibodies purified from therapeutic preparations of intravenous immunoglobulins (IVIg) induce the formation of autoimmune complexes in normal human serum: a role in the in vivo mechanisms of action of IVIg? | |
CN108431037A (zh) | 抗myl9抗体 | |
CN107474140A (zh) | Pcsk9特异性的结合蛋白mv072及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |